Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets
Crossref DOI link: https://doi.org/10.1208/s12249-015-0349-2
Published Online: 2015-07-23
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Claycamp, H. Gregg
Kona, Ravikanth
Fahmy, Raafat
Hoag, Stephen W.
Text and Data Mining valid from 2015-07-23